180 Life Sciences Corp. (ATNF) Soars 39.48% on Shareholder Approvals

On July 25, 2025, 180 Life Sciences Corp. (ATNF) experienced a significant surge in its stock price, rising by 39.48% in pre-market trading. This substantial increase can be attributed to several key developments within the company.

One of the primary factors driving the stock price increase is the approval of the Fourth Amendment to the 180 Life Sciences Corp. 2022 Omnibus Incentive Plan (OIP) by the company's shareholders. This amendment, which was originally approved by the Board of Directors on June 25, 2025, and became effective upon shareholder approval, allows for an increase in the number of shares that can be issued under the OIP. The aggregate number of shares of common stock which may be issued pursuant to awards under the OIP is initially 5,000,000, an increase of 4,000,000 shares from the number previously applicable. Additionally, the number of shares available under the OIP increases by 10% of the total shares of common stock outstanding on the last day of the immediately preceding fiscal year, for a period of seven years commencing on January 1, 2026.

Another significant development is the approval of the 180 Life Sciences Corp. 2025 Option Incentive Plan (2025 Option Plan) by the shareholders. This plan provides an opportunity for employees, officers, directors, or consultants of the Company to receive incentive stock options or nonqualified stock options. The aggregate number of shares of common stock which may be issued pursuant to awards under the 2025 Option Plan is 1,000,000, and as of the date of this Current Report on Form 8-K, all 1,000,000 awards have been granted by the Company.

Furthermore, the shareholders approved an amendment to the Company’s Second Amended and Restated Certificate of Incorporation to increase the Company’s authorized number of shares of common stock from one hundred million (100,000,000) shares to one billion (1,000,000,000) shares. This increase in authorized shares provides the company with greater flexibility in issuing new shares for various purposes, including employee compensation and strategic initiatives.